Glycotope: Daiichi Sankyo brings Glycotope antibody in-house for $132.5M

Daiichi Sankyo is spending $132.5 million to buy an antibody outright that it had already licensed from Glycotope. The one-off fee "satisfies" all milestone and royalty payments due to Glycotope under the terms of a ...